← board
LIFD
distress 2/10 · well-funded / low risk$0.190%today-42% from 52w high
Revenue
pre-revenue
Liquidity
$2M
Runway
—
Shares 1y
0%
Price & events
-17.4% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
+0.0%
1W
+18.8%
1M
-24.0%
3M
-17.4%
6M
-38.7%
1Y
-78.2%
2Y
-95.2%
5Y
-94.6%
All
Overview
- Market Cap
- $2.82M
- Volume
- 0
- 52 Week Range
- $0.15 – $0.33
- Total Shares
- 14.82M
- Float Shares
- 6.58M
- % Held by Insiders
- 58.47%
- % Held by Institutions
- 0.00%
- Beta
- 1.53
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 3
- 2025-04-11withdrawalTerminated five Letters of Intent for potential transactions.SEC 8-K
- 2025-02-19partnershipEntered LOI to acquire TMD VenturesSEC 8-K
- 2025-02-19partnershipEntered LOI to acquire Sustainable Innovations' marijuana subsidiariesSEC 8-K
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 14,822,678 · 0 offerings/1y · 0 PIPEs
- 2025-04-048-Kmaterial_agreement
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.